FDA Inspection
Pierre Fabre Pharmaceuticals, Inc.Pierre Fabre Pharmaceuticals, Inc. – FDA Inspection, Dec 30, 2015
Record Details
This FDA Inspection record concerns Pierre Fabre Pharmaceuticals, Inc., with an inspection on December 30, 2015, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- December 30, 2015
- Product Type
- Drugs
View Company Profile
ID · 140fdda4-ba34-4f68-82d6-163a0645a609
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 956345
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 314.80(c)(1)(i)Late submission of 15-day report
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Pierre Fabre Pharmaceuticals, Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| November 1, 2024 | VAI | New Jersey District Office | Postmarketing Surveillance and Epidemiology: Human Drugs |
| July 27, 2022 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Pierre Fabre Pharmaceuticals, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.